4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-018153
EVP, Research & CSO acquired 9,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2022-03-10 | Option exercise | +9,000 | $1.53 | $13,770 | 184,407 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2022-03-10 | Option exercise · Stock Option (Right to Buy) | −9,000 | 210,505 | D | ||
Loading xslF345X03/doc4.xml…